Reuters logo
BRIEF-Brainstorm Cell Therapuetics Q4 loss per share $0.03
March 30, 2017 / 5:01 AM / 6 months ago

BRIEF-Brainstorm Cell Therapuetics Q4 loss per share $0.03

March 30 (Reuters) - Brainstorm Cell Therapuetics Inc

* Brainstorm announces financial results for 2016 and provides business update

* Q4 loss per share $0.03 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below